by Christie Knapper | May 4, 2021 | News
Small Business Innovation Research Program Provides Seed Funding for R&D [Knoxville, TN], April 26, 2021 – NellOne Therapeutics, Inc. (NellOne) has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant for...
by Bandera Admin | Nov 10, 2020 | News
The novel coronavirus is no doubt top of mind for most people with the infection numbers rising rapidly on a daily, so an announcement last week from Oak Ridge National Laboratory (ORNL) that involves a local early stage biopharmaceutical...
by Bandera Admin | Nov 5, 2020 | News
NellOne Therapeutics of Knoxville, Tenn., has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19. The technology...
by Bandera Admin | Oct 27, 2020 | News
By Sarah Marshall, Uniformed Services University of the Health Sciences WASHINGTON — Efforts are underway at the Uniformed Services University of the Health Sciences to support the fight against the pandemic, including some that apply existing research and...
by Bandera Admin | Sep 22, 2020 | News
You don’t want to miss this interview by Brandon Bruce of Startup Knox with Knoxville serial entrepreneur Bill Malkes about his newest company NellOne Therapeutics. Click to view podcast on original website
by Bandera Admin | Aug 26, 2020 | News
NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, today announced that the United States Patent and Trademark Office (“USPTO”) yesterday issued U.S. Patent No. 10,752,663 with...
